• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Gilead Sciences Inc

+ Add to Watchlist

GIS:GR

68.000 EUR 0.600 0.89%

As of 06:08:45 ET on 07/25/2014.

Snapshot for Gilead Sciences Inc (GIS)

Open: 67.573 Day's Range: 66.920 - 68.220 Volume: 8,276
Previous Close: 67.400 52wk Range: 41.815 - 68.900 1-Yr Rtn: +49.78%

Stock Chart for GIS

No chart data available.
  • GIS:GR 68.000
  • 1D
  • 1M
  • 1Y
67.400
Interactive GIS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GIS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 12.2838
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 7.4230
Est. PEG Ratio 0.4727
Market Cap (M EUR) 104,117.71
Shares Outstanding (M) 1,535.68
30 Day Average Volume 10,812
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GIS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GIS

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.

John C MartinChairman/CEOJohn F MilliganPresident/COO
Robin L WashingtonExec VP/CFOJohn G McHutchisonExec Vice President
More Company Profile & Key Executives for GIS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil